Blood coagulation protein antagonists and uses therefor

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4241581, 5303887, 53038825, A61K 39395, C07K 1600, C07K 1618

Patent

active

058434429

ABSTRACT:
Coagulation protein antagonists are disclosed, which include monoclonal-type antibodies and related cell lines disclosed for the production of specific, neutralizing antibodies against factors VII and VIIa and the tissue factor/factor VIIa bimolecular complex, which antibodies are useful for the prevention or treatment of thrombotic and related diseases, for immunoaffinity isolation and purification of factors VII and VIIa and the tissue factor/factor VIIa complex, and for determination of factors VII or VIIa and the tissue factor/factors VII or VIIa complex in a biological sample.

REFERENCES:
patent: 4382083 (1983-05-01), Thomas
Carson et al, Blood, 70(2):490-493, Aug. 1987.
Takase et al, J. Clin Pathol, 41:337-341, 1988.
Higashi et al, J. Biochem, 108:654-662, 1990.
Drake et al, J. Cell Biol, 109:389-395, Jul. 1989.
Drake et al, Am J Pathol, 134(5):1087-1097, May 1989.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Blood coagulation protein antagonists and uses therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Blood coagulation protein antagonists and uses therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Blood coagulation protein antagonists and uses therefor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2393440

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.